Literature DB >> 1359800

Implications of the revised surveillance definition: AIDS among New York City drug users.

D C Des Jarlais1, J Wenston, S R Friedman, J L Sotheran, R Maslansky, M Marmor, S Yancovitz, S Beatrice.   

Abstract

The Centers for Disease Control (CDC) has proposed revising the AIDS surveillance definition to include any HIV-seropositive person with a CD4 cell count of less than 200 cells per microliter. Based on a study of persons receiving treatment for HIV infection, this new definition would lead to an estimated 50% increase in the number of persons recognized as living with AIDS. Among 440 HIV-seropositive research subjects recruited from drug treatment programs and through street outreach in New York City, 59 met this definition, yet only 25% of those had been reported to the New York City AIDS registry. The new definition, if combined with HIV and T-cell testing at drug treatment and street outreach programs, could thus yield very large increases in the number of injecting drug users meeting the new surveillance definition of AIDS.

Entities:  

Mesh:

Year:  1992        PMID: 1359800      PMCID: PMC1694601          DOI: 10.2105/ajph.82.11.1531

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.

Authors:  D C Des Jarlais; S R Friedman; M Marmor; H Cohen; D Mildvan; S Yancovitz; U Mathur; W el-Sadr; T J Spira; J Garber
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

2.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

Review 3.  Care of women infected with the human immunodeficiency virus.

Authors:  H L Minkoff; J A DeHovitz
Journal:  JAMA       Date:  1991 Oct 23-30       Impact factor: 56.272

4.  A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.

Authors:  R L Stoneburner; D C Des Jarlais; D Benezra; L Gorelkin; J L Sotheran; S R Friedman; S Schultz; M Marmor; D Mildvan; R Maslansky
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

5.  Spectrum of disease in persons with human immunodeficiency virus infection in the United States.

Authors:  K M Farizo; J W Buehler; M E Chamberland; B M Whyte; E S Froelicher; S G Hopkins; C M Reed; E D Mokotoff; D L Cohn; S Troxler
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

6.  Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.

Authors:  J B Margolick; A Muñoz; D Vlahov; L Solomon; J Astemborski; S Cohn; K E Nelson
Journal:  JAMA       Date:  1992-03-25       Impact factor: 56.272

7.  Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.

Authors:  P A Selwyn; A R Feingold; D Hartel; E E Schoenbaum; M H Alderman; R S Klein; G H Friedland
Journal:  AIDS       Date:  1988-08       Impact factor: 4.177

  7 in total
  2 in total

1.  The surveillance definition for AIDS.

Authors:  J W Buehler
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

2.  Human immunodeficiency virus disease in California. Effects of the 1993 expanded case definition of the acquired immunodeficiency syndrome.

Authors:  J A Singleton; F Tabnak; J Kuan; G W Rutherford
Journal:  West J Med       Date:  1996-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.